First-in-human transplantation of CRG-002, an iPSC-derived universal islet product for type 1 diabetes (EASD 2026) - Jul 21, 2026 - Abstract #LBA 05; Pres time: Sep 29, 2026; 11:00 AM - 11:15 AM; Location: Vienna Hall; P1 | "CRG-002 achieves potent, durable glycemic control with an excellent safety profile in the first T1D patient. These proof-of- concept findings strongly support further clinical development of CRG-002 as a scalable functional cure for type 1 diabetes."
First-in-human • Late-breaking abstract • P1 data • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus
|
|
B. Sun 1; M. Zheng 2; L. Li 2; D. Deng 1; H. Zhou 1; S. Meng 2
|